Trial intelligence / Profile preview

ePREDICE trial in adults with prediabetes

2013-000418-39Phase 3Completed

Sponsor
Evidem Consultores
Start
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of linagliptin and metformin in prediabetes and hyperglycemia (4 arms), sponsored by Evidem Consultores. Primary endpoint: Microvascular complication index. Started Oct 2014; status: completed.

02

Drugs

linagliptinmetformin
03

Conditions

prediabeteshyperglycemia

Beyond the preview

Go deeper on 2013-000418-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-000418-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call